Clinical Trial Update: Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy plus radiation with or without amifostine for locally advanced nasopharyngeal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nasopharyngeal Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer | Phase 2 | Status: TERMINATED